Literature DB >> 24933731

Phosphorylation of Akt at the C-terminal tail triggers Akt activation.

Pengda Liu1, Zhiwei Wang2, Wenyi Wei1.   

Abstract

Aberrant hyper-activation of the protein kinase Akt plays a critical role in promoting tumorigenesis. Mechanistically, previous studies establish that phosphorylation of Akt at S473 and T308 by mTORC2 and PDK1, respectively, is necessary for its full activation, thereby having been used as Akt activation markers. Recently, we report that phosphorylation of S477 and T479 at the extreme C-terminus of Akt1 promotes Akt1 activation. We further demonstrate that Akt1 pS477 and pT479 events are governed by Cdk2/Cyclin A or mTORC2 under distinct cellular contexts such as cell cycle progression or growth stimulation conditions. Here, we summarize our major findings regarding the biological significance for pS477/pT479-mediated activation of Akt and also provide perspectives for future follow-up studies.

Entities:  

Keywords:  Cancer signaling; Cdk2/Cyclin A; mTOR/Akt pathway; mTORC2; phosphorylation; protein kinase

Mesh:

Substances:

Year:  2014        PMID: 24933731      PMCID: PMC4111671          DOI: 10.4161/cc.29584

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  10 in total

1.  Proliferation of cancer cells despite CDK2 inhibition.

Authors:  Osamu Tetsu; Frank McCormick
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

Review 2.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

Authors:  Ji Luo; Brendan D Manning; Lewis C Cantley
Journal:  Cancer Cell       Date:  2003-10       Impact factor: 31.743

Review 3.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

4.  Cell-cycle-regulated activation of Akt kinase by phosphorylation at its carboxyl terminus.

Authors:  Pengda Liu; Michael Begley; Wojciech Michowski; Hiroyuki Inuzuka; Miriam Ginzberg; Daming Gao; Peiling Tsou; Wenjian Gan; Antonella Papa; Byeong Mo Kim; Lixin Wan; Amrik Singh; Bo Zhai; Min Yuan; Zhiwei Wang; Steven P Gygi; Tae Ho Lee; Kun-Ping Lu; Alex Toker; Pier Paolo Pandolfi; John M Asara; Marc W Kirschner; Piotr Sicinski; Lewis Cantley; Wenyi Wei
Journal:  Nature       Date:  2014-03-09       Impact factor: 49.962

5.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.

Authors:  L Stephens; K Anderson; D Stokoe; H Erdjument-Bromage; G F Painter; A B Holmes; P R Gaffney; C B Reese; F McCormick; P Tempst; J Coadwell; P T Hawkins
Journal:  Science       Date:  1998-01-30       Impact factor: 47.728

6.  The E3 ligase TRAF6 regulates Akt ubiquitination and activation.

Authors:  Wei-Lei Yang; Jing Wang; Chia-Hsin Chan; Szu-Wei Lee; Alejandro D Campos; Betty Lamothe; Lana Hur; Brian C Grabiner; Xin Lin; Bryant G Darnay; Hui-Kuan Lin
Journal:  Science       Date:  2009-08-28       Impact factor: 47.728

7.  Dysregulation of the mTOR pathway in p53-deficient mice.

Authors:  Olga V Leontieva; Liliya R Novototskaya; Geraldine M Paszkiewicz; Elena A Komarova; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2013-11-01       Impact factor: 4.742

Review 8.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 9.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

10.  Rapamycin reverses insulin resistance (IR) in high-glucose medium without causing IR in normoglycemic medium.

Authors:  O V Leontieva; Z N Demidenko; M V Blagosklonny
Journal:  Cell Death Dis       Date:  2014-05-08       Impact factor: 8.469

  10 in total
  11 in total

1.  Angiomotin-like 2 interacts with and negatively regulates AKT.

Authors:  H Han; B Yang; W Wang
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

Review 2.  AKTivation mechanisms.

Authors:  Philip A Cole; Nam Chu; Antonieta L Salguero; Hwan Bae
Journal:  Curr Opin Struct Biol       Date:  2019-03-20       Impact factor: 6.809

3.  Peripheral tissular analysis of rapamycin's effect as a neuroprotective agent in vivo.

Authors:  Alfredo Gonzalez-Alcocer; Yareth Gopar-Cuevas; Adolfo Soto-Dominguez; Maria de Jesus Loera-Arias; Odila Saucedo-Cardenas; Roberto Montes de Oca-Luna; Humberto Rodriguez-Rocha; Aracely Garcia-Garcia
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-27       Impact factor: 3.195

4.  Fine-tuning AKT kinase activity through direct lysine methylation.

Authors:  Jianping Guo; Wenyi Wei
Journal:  Cell Cycle       Date:  2019-05-03       Impact factor: 4.534

5.  RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.

Authors:  Francesca Pentimalli; Iris M Forte; Luca Esposito; Paola Indovina; Carmelina A Iannuzzi; Luigi Alfano; Caterina Costa; Daniela Barone; Gaetano Rocco; Antonio Giordano
Journal:  Oncogene       Date:  2018-04-02       Impact factor: 9.867

Review 6.  Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond.

Authors:  Dudley W Lamming
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

Review 7.  Lysosome: The metabolic signaling hub.

Authors:  Dudley W Lamming; Liron Bar-Peled
Journal:  Traffic       Date:  2018-11-14       Impact factor: 6.215

8.  Tizanidine hydrochloride exhibits a cytotoxic effect on osteosarcoma cells through the PI3K/AKT signaling pathway.

Authors:  Xue-Wu Xing; Yu-Fu Sun; Jun Zhao; Zi-Xiang Pan; Wen-Xue Jiang
Journal:  J Int Med Res       Date:  2019-06-10       Impact factor: 1.671

9.  A Recombinant Affinity Reagent Specific for a Phosphoepitope of Akt1.

Authors:  Jennifer E McGinnis; Leon A Venegas; Hector Lopez; Brian K Kay
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

Review 10.  mTORC2: The other mTOR in autophagy regulation.

Authors:  Josué Ballesteros-Álvarez; Julie K Andersen
Journal:  Aging Cell       Date:  2021-07-12       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.